Recent Advances in Cancer Treatment (REACT) 2023
International Conference
ABOUT THE EVENT
At the REACT 2023 online event, Sheba aims to empower healthcare professionals by exploring the latest advances in breast cancer treatment, hemato-oncology, cancer immunotherapy, and AI-driven personalized care. Attend to hear from some of the world’s leading oncology experts in a global, online event.
Pricing & Accreditation
Participation in REACT 2023 involves a fee of 19.90$. All attendees will be entitled to a certificate of participation.
- July 27, 2023
- Online event
-
Add to Calendar
AGENDA
Empowering Clinicians to Advance Cancer Care
Following opening remarks and short introductory presentations, attendees can expect five professional lectures from Sheba’s leading clinicians on the latest in cancer research and care.
15:00
Opening Remarks
Vered Cohen-Herszaft
Director of Global Patient Services
15:05
The Israeli Healthcare System, Sheba & Its Global Activities
Following a short overview of the Israeli healthcare system, Dr. Har-Even will briefly explore Sheba’s activities: locally and globally, discussing its mission and impact on healthcare.
Yoel Har-Even, Ph.D.
Head of Sheba Global
15:10
The Sheba REACT Community
As part of a brief introduction to the REACT Community, Mrs. Amram and Mr. Akivaev will explore its establishment, activities, and plans for the future.
Mika Amram
Business Development & Process Control Manager
Hanan Akivaev
REACT Community Manager
15:15
IOeRT in Breast Cancer – Principles and Clinical Experience
Intraoperative electron radiation therapy is a precision radiotherapeutic approach that allows delivering high doses of radiation while preventing harm to healthy surrounding tissues. Join Prof. Zippel as he explores the advanced treatment and shares experiences from its use at Sheba’s Meirav Breast Health Center.
Prof. Douglas (Dov) Zippel M.D. FACS
Director of the Meirav Breast Health Center
Deputy Chief of Surgery C and Surgical Oncology Departments
15:50
CAR T-Cell Therapy for Hematological Malignancies: The Sheba Experience
Join Prof. Nagler, a recognized global leader in the field of CAR T-cell therapy, as he explores clinical results, recent advances, and the CAR T-cell therapeutic process at Sheba.
Prof. Arnon Nagler, M.D., M.Sc
President of the Hemato-Oncology Center
Co-Chair of EBMT’s ALWP Molecular-Markers Subcommittee
16:40
Immunotherapy and Gyneco-Oncology
Join Dr. Shapira-Frommer as she explores the latest advanced cervical cancer and endometrial cancer immunotherapy approaches, including the use of monoclonal antibodies, multiple kinase inhibitors, and more.
Dr. Ronnie Shapira-Frommer, M.D.
Head of the Onco-Gynecological Cancer Unit
17:30
Innovations in Pediatric Hemato-Oncology
Join Prof. Toren as he explores the latest pediatric hemato-oncology therapeutic approaches, including the use of monoclonal antibodies, stem cell transplants, advanced cell therapies, advanced targeted therapies, preventative oncology and more.
Prof. Amos Toren M.D.
Director of the Pediatric Hemato-Oncology and BMT Division
18:25
Hyperpersonalization in Cancer Medicine: Technologies in the Big Data and AI Era
Recent years saw an incredible jump forward in the development and application of healthcare AI technologies. These technologies allow physicians to provide personalized care, informing clinical decision-making by leveraging vast databases of comparable cases and advanced algorithms.
Prof. Raanan Berger, M.D, Ph.D,
Director of the Jusidman Oncology Hospital
18:50
Closing Remarks
Vered Cohen Herszaft
Head of Global Patient Services
EVENT SPEAKERS
Yoel Har-Even, Ph.D
Head of Sheba Global
Prof. Douglas (Dov) Zippel M.D. FACS
Director of the Meirav Breast Health Center
Deputy Chief of Surgery C and Surgical Oncology Departments
Prof. Arnon Nagler, M.D., M.Sc
President of the Hemato-Oncology Center
Co-Chair of EBMT’s ALWP Molecular-Markers Subcommittee
Prof. Raanan Berger, M.D, Ph.D
Director of the Jusidman Oncology Hospital
Dr. Ronnie Shapira-Frommer, M.D
Head of the Onco-Gynecological Cancer Unit
Prof. Amos Toren, M.D, Ph.D, MHA
Director of the Pediatric Hemato-Oncology and BMT Division
WHY SHOULD YOU ATTEND?
Access
To leading cancer experts from one of the world’s best hospitals.
Knowledge
Concerning the latest advances in oncologic care.
Networking
With Sheba experts and colleagues across the globe.
SHEBA MEDICAL CENTER:
A GLOBAL LEADER IN HEALTHCARE
Established in 1948, Sheba Medical Center, Israel’s City of Health, is the largest, most comprehensive healthcare facility in the Middle East and one of the best hospitals in the world for the last five years running according to Newsweek magazine.
With over 1,700 physicians, 1.9 million patients treated annually, and 4,000 active research projects, Sheba is a recognized leader in both clinical care and medical research. As outlined in its creed, ‘Hope Without Boundaries,’ Sheba is committed to helping provide patients everywhere the best possible care by sharing its knowledge and experience with healthcare professionals, governments, and medical institutions.
Join the Event!
React 2023 – Registration
FREQUENTLY ASKED QUESTIONS
Who should attend the REACT 2023 online event?
While we invite all practising doctors to attend, oncologists will be the primary beneficiaries of the event.